Despite its use in other European countries, England's rationing body said lapatinib, last chance' drug is too expensive even though its makers will provide the first three months' treatment free of charge. Only a few women would qualify for the drug and it would extend their lives, however NICE feels that it isn't cost effective. picked by 2manyusernames 1 month ago tags breast cancer nice england lapatinib |
| quote edit #1 |
|
![]() | syndication |